PUBLISHER: BIS Research Inc. | PRODUCT CODE: 1019576
PUBLISHER: BIS Research Inc. | PRODUCT CODE: 1019576
“Global Radiation Therapy in the Oncology Market to Reach $9,206.6 Million by 2031.”
Accuray Inc., Eckert & Ziegler AG, Elekta AB, General Electric Company, Hitachi Ltd., Ion Beam Applications SA, Koninklijke Philips N.V., Mevion Medical Systems Inc., TeamBest Group, Reflexion Medical Inc., Sensus Healthcare Inc., Varian Medical Systems Inc. (Siemens Healthineers AG), Xoft Inc. (iCAD Inc.), Xstrahl Inc., Zap Surgical Systems Ltd.
Radiation therapy in the oncology market is a treatment method to treat any type of cancer/ tumor with the help of radiation. Radiation therapy uses radiation beams made of photon, proton, heavy-ion, and other particles. These radiation beams of intense energy are used to destroy or shrink the cancer/ tumor cells.
The term 'radiation therapy' mostly refers to the external beam radiation therapy, but it also means internal beam radiation therapy too. The external beam radiation therapy is done with the help of a machine outside the patient's body that produces high-energy radiation beam and then aims the beam to a localized precise point or area of treatment on the patient's body. Whereas the internal beam radiation therapy is a method to place radiation (radioactive source) inside the patient's body.
The radiation therapy systems (machines) available in the market are, namely, linear accelerator (LINAC), cyclotrons, synchrotrons, synchrocyclotrons, and conventional and electronic brachytherapy systems.
The radiation therapy in oncology report highlights that the market was valued at $5,481.8 million in 2020 and is expected to reach $9,206.6 million by the end of 2031. The market is expected to grow at a CAGR of 5.0% during the forecast period from 2021 to 2031.
Presently, the factors driving the growth of the market as per the radiation therapy report include rising incidence and prevalence of neoplastic patients, elevating geriatric population, rising demand for reduced radiation exposure during radiotherapy, technological advancements in the field of radiotherapy.
All the radiation therapy systems, such as external beam radiation systems or internal beam radiation systems are based on using radiation beam to treat cancer/tumor. The radiation beam destroys the cell's DNA thus, resulting in the shrinkage or destruction of the cancer/ tumor. This cancer/ tumor treatment by radiation beam has resolved treatment of complex cancer/ tumor and providing less side effects when compared to traditional radiation therapy by x-ray or cobalt-60, or chemotherapy.
The challenges that are restricting the growth of the market include high cost of radiotherapy systems and their associated procedures, and highly regulated market due to the use of radioactivity.
High cost of the system and their associated procedures are among the most challenging factors for the end-user to buy and treatment delivery for patients. It has been observed that many patients prefer international travel for their treatment to take the advantage of currency rate. Also, due to the highly regulated market because of the use of the radioactivity have led the company to strictly obey the regulations to commercialize their products. Lack of accuracy in beam or radiation dose delivery is another factor affecting the growth of the global radiation therapy in oncology market.
Potential opportunities that is likely to boost the growth of the market include development of low-cost cancer treatment centers, developing radiation therapy system which is cost effective, and implementation of machine learning in radiation therapy system.
The current radiation therapy systems have a price of more than $2 million, therefore many companies are working in developing cost-effective system and even working towards the development of a low-cost infrastructure facility for the radiation therapy. And with time, technologically advanced products are being working, researched to get an upgraded product.
The neoplastic patients were at concern with their need for timely diagnosis, treatment, and symptom palliation due to the pandemic lockdown. During the pandemic, there was an increased number of treatments for some cancers and on the other hand, some radiotherapy treatments fell significantly. The increase in the number of cancer treatments via radiation therapy was due to reduced surgical procedures, which lead the doctors to give radiation therapy as an alternative solution for the surgery.
In response to safety from the COVID-19 virus. professional bodies internationally issued guidance for cancer care. The suggestions were treatment omission or delay, utilizing radiation therapy to replace or to bridge to surgery, and use of short and high-daily-dose (HDR or hypo-fractionated) radiotherapy.
Under this segmentation, the radiation therapy market in divided into external beam radiation and internal beam radiation.
The external beam radiation segment dominates the market with a share of 82.8% of global radiation therapy market mainly due to the more treatment processes being conducted by external beam radiation therapy systems.
Internal beam radiation segment is expected to register a higher CAGR then external beam radiation segment, the CAGR is 6.7% during the forecast period.
Under this segmentation, the radiation therapy market in divided into oncology systems, particle therapy systems (proton and heavy-ion), and others.
The oncology systems segment which consists traditional radiation therapy systems (x-ray, gamma, cobalt-60 external beam radiation therapy systems, and internal beam radiation therapy systems, among others) dominates the radiation therapy market with a share of 81.9% of global radiation therapy market mainly due to the number of installed bases of traditional systems and internal beam radiation therapy systems, number of procedures being conducted, and the cost of the systems and the procedure when compared with the proton or heavy-ion radiation therapy systems.
Particle therapy systems (proton and heavy-ion) segment is expected to register a higher CAGR of 7.5% during the forecast period.
Under this segmentation, the radiation therapy market in divided into stereotactic radiosurgery (SRS), brachytherapy, image-guided radiation therapy (IGRT), intensity-modulated radiation therapy (IMRT), and volumetric-modulated arc therapy (VMAT).
The stereotactic radiosurgery (SRS) segment dominates the radiation therapy market with a share of 40% of global market mainly due to the number of procedures being performed by the surgeons and clinicians.
Volumetric-modulated arc therapy segment is expected to register a higher CAGR of 6.8% during the forecast period.
Under this segmentation, the radiation therapy market in divided into hospitals and medical research institutes, and specialized radiotherapy centers (SRCs).
The hospitals and medical research institutes segment dominates the radiation therapy market with a share of 84.5% of global market mainly due to the number of hospitals, medical and research institutes providing access to the radiotherapy for the patients.
Specialized radiotherapy centers (SRCs) segment is expected to register a higher CAGR of 6.2% during the forecast period.
The different regions covered under the radiation therapy in oncology market report includes North America, Europe, Asia-Pacific, and Rest-of-the-World.
North America dominates the radiation therapy market in 2020 and is anticipated to uphold its dominance throughout the forecast period. The growth in the market is majorly driven by the increasing research and development activities and many companies being located in the U.S.
Asia-Pacific market is expected to grow with a higher CAGR of 5.8% during the forecast period.
Some of the key players operating in the market, include Accuray Inc., Eckert & Ziegler AG, Elekta AB, General Electric Company, Hitachi Ltd., Ion Beam Applications SA, Koninklijke Philips N.V., Mevion Medical Systems Inc., TeamBest Group, Reflexion Medical Inc., Sensus Healthcare Inc., Varian Medical Systems Inc. (Siemens Healthineers AG), Xoft Inc. (iCAD Inc.), Xstrahl Inc., Zap Surgical Systems Inc.
The radiation therapy market market has witnessed several strategic and technological developments in the past four years, undertaken by the different market players to attain their respective market shares in this emerging domain. Some of the strategies covered in this segment are product development and upgradations, partnerships, collaborations, business expansions, funding activities, regulatory approvals, mergers, and acquisitions. The preferred strategy for companies has been partnerships, collaborations, and business expansions.